Who We Are

Your Middle Market Partner

Scale, relationships, and stability with an entrepreneurial spirit: unlocking opportunities for clients and sponsors across the alternatives landscape

$41B

in AUM

320+

Sponsor Relationships

2,700+

Investments

$75B+

Committed

Apogem Capital is a leading alternatives investor, with decades of experience investing in the middle market. By offering a full range of capital solutions, Apogem delivers innovative solutions to sponsors and portfolio companies while generating access to highly sought-after opportunities for our clients.

Apogem is a wholly owned subsidiary of New York Life, one of the world’s largest life insurers, with a 175-year history and the highest financial strength ratings currently awarded to any US life insurer from all four of the major credit rating agencies.

Scale and Resources: formed in 2022 by combining GoldPoint Partners, Madison Capital Funding, and PA Capital, Apogem manages $41 billion in assets

Middle Market Specialists: our long-term focus and deep relationships, experience, and data allow greater access to top-tier investment opportunities

Broad Array of Established Strategies: experienced investors across private credit, private equity, GP stakes, private real assets, and long/short equity

Financial Stability with Long-Term Focus: our clients are invested in select strategies alongside our parent company New York Life, one of the largest life insurers in the world and a leading investor in alternatives

History

A New Name with a Long History

Apogem Capital is a new name for three firms, combining our specialized investment capabilities as we seek to generate more value for clients and sponsors. The name “Apogem” is derived from the word “apogee” and reflects our history as leaders in alternatives investing, continually pushing our strategies to new heights.

1845

New York Life, now one of the largest life insurance companies globally, founded.

1991

GoldPoint Partners begins investing in private equity funds, co-investments, and private debt transactions alongside middle market sponsors.

1997

PA Capital (formerly known as Private Advisors) begins investing in private equity and long/short equity funds.

2001

Madison Capital Funding is established as a subsidiary of New York Life to make senior loan investments.

2010

PA Capital enters into a strategic partnership with New York Life, joining GoldPoint and Madison under the NYL Investments umbrella.

2012-2014

PA Capital launches private equity secondaries and private real assets strategies.

2020

PA Capital launches GP stakes strategy in partnership with Ottawa Avenue Private Capital.

2020

New York Life Investments Alternatives formed to facilitate greater collaboration among GoldPoint, Madison, and PA Capital.

2022

Apogem Capital formed creating a leading middle market alternatives investor.

Why Apogem Capital

Middle Market Investing Specialists

We believe the middle market presents the most compelling investment opportunity across the alternatives landscape. We help sponsors and clients achieve their goals by delivering innovative solutions as a value-added partner.

We seek to unlock value in the middle market for clients and sponsors

Access to Highly Sought-After Deal Flow

With deep relationships and data in the middle market, Apogem sources from established and early evolution sponsors, creating a deep pool of opportunities and enabling us to be highly selective

Multi-Cycle Track Record

Decades of experience investing across multiple economic and credit cycles enable Apogem to navigate all markets

Entrepreneurial Spirit & Strong Alignment

We are continually evolving to remain at the forefront of the alternatives landscape. Clients are invested in select strategies alongside New York Life, a leading investor in alternatives.

Responsibility

Strong Values Build Strong Performance

We believe that investing responsibly is essential to building long-term relationships, generating attractive returns, and mitigating risk.

We have distinct responsibilities to our clients, sponsors, employees, and the communities where we live, work, and invest. We believe our focus on the middle market and emphasis on business building is strongly aligned with responsible investing principles.

Environmental, Social, and Governance (ESG): For more than two decades, we have considered ESG factors integral to assessing investment risk and potential value drivers. Across our strategies, these factors have been formally incorporated into our investment evaluation and monitoring processes to ensure we are systematically accounting for and monitoring ESG-related considerations.

Diversity, Equity, and Inclusion (DEI): To address the lack of diversity in the private equity market, Apogem launched its Social Advancement strategy in 2021, which focuses on supporting diverse managers raising their first or second fund. This strategy is led by our diverse, long-tenured private equity team and dedicated investment committee, reflecting Apogem’s longstanding commitment to diversity.

Community Involvement: We recognize the importance of giving back to the community. Throughout our histories, we have made a difference through partnerships with numerous organizations, including Year Up, EPIC Academy, Cradles to Crayons, and Partnership for the Future, and have partnered with the New York Life Foundation on multiple charitable giving campaigns.

X

Apogem SFDR website disclosure EU Sustainable Finance Disclosure Regulation (2019/2088) (“SFDR”)

The EU Sustainable Finance Disclosures Regulation (2019/2088) on sustainability-related disclosures in the financial services sector (the “SFDR”) requires Apogem Capital LLC (“Apogem”) to publish information on the integration of sustainability risks in its investment decision making process and the consideration of adverse sustainability impacts. The following disclosures apply only in respect of those funds managed by Apogem that are subject to SFDR.

Integration of Sustainability Risks in Investment Decision-Making Process

A “sustainability risk” means “an environmental, social or governance event or condition that, if it occurs, could cause an actual or potential material negative impact on the value of the investment”.

Apogem is committed to considering ESG factors and sustainability risks in the course of its due diligence, its investment decisions, and investment monitoring, to the extent reasonably practicable under the circumstances and where consistent with its fiduciary responsibilities.

Apogem’s ESG policy is available on request. In addition, Apogem may apply specific ESG policies and frameworks, and approaches appropriate to particular investment strategies where relevant.

Principal Adverse Impacts

Adverse impact under SFDR is the risk of harm that an investment decision may have externally on sustainability factors. Sustainability factors are defined under the SFDR as environmental, social and employee matters, respect for human rights, anti-corruption and anti-bribery matters.

Apogem does not consider the adverse impacts of its investment decisions on sustainability factors, within the meaning of Article 4(1)(a) of the SFDR and the technical standards made under the SFDR in relation to the funds that it makes available in the EU. Among other reasons, Apogem does not consider it reasonable nor proportionate in relation to the type of investment strategies and funds that it makes available to systematically collect or report on data in relation to principal adverse impacts on investment decisions on sustainability factors in line with the technical standards set out by the SFDR in relation to the funds it manages. Apogem’s position on this topic will be reviewed on a periodic basis.

Remuneration Policy

In addition to traditional financial metrics, remuneration of Apogem’s personnel is also calculated using non-financial metrics and performance indicators. Apogem is not subject to Article 5 SFDR with respect to remuneration.

Recent News & Insights